Essential Skills/Experience:
• Graduate of a recognized school of medicine with an MD degree or equivalent with board-certification in pulmonology
• Demonstrated clinical research expertise in Pulmonology (especially in COPD and bronchiectasis)
• Pharma industry experience in clinical drug development for at least 10 years
• Experience in early and late stage program development and trial conduct
• Developed/delivered in parallel multiple complex and/or large studies (e.g., including but not limited to global, pivotal Phase 3 efficacy studies)
• Demonstrated ability to lead the development of a program strategy (e.g., Clinical Development Plans) and be accountable for project plans, timelines, progress, and outcomes
• Writing and delivery of global regulatory submissions (e.g., NDA/BLA submissions, benefit/risk assessment) and interacting with major Health Authorities (e.g., FDA, EMA, PMDA, CDE)
• Demonstrated ability leading and motivating teams in a matrix environment
• Demonstrated ability to lead, coach, and mentor physicians and other clinical scientists
• Significant hands-on clinical drug development experience and scientific credibility
• Demonstrated ability to cultivate excellent cross-functional collaborations
• Demonstrated ability to effectively communicate at multiple levels of the organization
• Must demonstrate high integrity
• Organize and deliver Advisory Boards with international Key Opinion Leaders (KOLs)
• Demonstrated AI/digital mindset and experience applying AI-enabled and generative AI tools to support clinical development activities (e.g., data analysis, medical writing, clinical trial operational efficiency)